Magdalena Ankiersztejn-Bartczak
Overview
Explore the profile of Magdalena Ankiersztejn-Bartczak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
23
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Szczepanski A, Klesiewicz K, Ankiersztejn-Bartczak M, Drozdz K, Szetela B, Olechowska-Jarzab A, et al.
HIV Med
. 2024 May;
25(9):1040-1050.
PMID: 38773822
Objective: Voluntary counselling and testing points (VCTs) offer anonymous and free HIV tests in Poland. They also play an essential role in educational initiatives focused on the prevention and diagnosis...
2.
Walendzik-Ostrowska A, Majka R, Dec-Pietrowska J, Brodzikowska M, Ankiersztejn-Bartczak M
Przegl Epidemiol
. 2024 Feb;
77(3):302-316.
PMID: 38329029
The article is an attempt to collect and describe non-medical aspects of the HIV epidemic in Poland in 2023, aspects that often elude epidemiology and treatment specialists. However, they are...
3.
Jordans C, Vasylyev M, Rae C, Jakobsen M, Vassilenko A, Dauby N, et al.
Euro Surveill
. 2023 Jan;
27(48).
PMID: 36695464
BackgroundAdequate identification and testing of people at risk for HIV is fundamental for the HIV care continuum. A key strategy to improve timely testing is HIV indicator condition (IC) guided...
4.
Ankiersztejn-Bartczak M, Kowalska J
Przegl Epidemiol
. 2022 Feb;
75(3):347-354.
PMID: 35170290
Objective: The objective of this study is to conduct a pilot program for self-testing for HIV during the SARS-CoV-2 pandemic. The target population was the partners of newly diagnosed HIV...
5.
Gasbarrini N, Dubravic D, Combs L, Diskovic A, Ankiersztejn-Bartczak M, Colaiaco F, et al.
BMC Infect Dis
. 2021 Sep;
21(Suppl 2):874.
PMID: 34517819
Background: Maximising access to testing by targeting more than one infection is effective in identifying new infections in settings or populations. Within the EU funded Joint Action INTEGRATE, this paper...
6.
Kowalska J, Ankiersztejn-Bartczak M, Shepherd L, Mocroft A
Infection
. 2018 May;
46(4):533-540.
PMID: 29785614
Introduction: Early treatment remains the most effective HIV prevention strategy; poor linkage to care after HIV diagnosis may compromise this benefit. We sought to better understand patient characteristics and their...
7.
Kowalska J, Wojcik G, Rutkowski J, Ankiersztejn-Bartczak M, Siewaszewicz E
PLoS One
. 2017 Nov;
12(11):e0186131.
PMID: 29131849
Background: HIV epidemic remains a major global health issue. Data from cost-effectiveness analyses base on CD4+ count and morbidity in patients with symptomatic and asymptomatic HIV infection. The approach adopted...
8.
Kowalska J, Shepherd L, Ankiersztejn-Bartczak M, Cybula A, Czeszko-Paprocka H, Firlag-Burkacka E, et al.
PLoS One
. 2016 Oct;
11(10):e0162739.
PMID: 27711159
Background: The main objective of the TAK project is investigating barriers in accessing HIV care after HIV-diagnosis at the CBVCTs of central Poland. Here we describe factors associated with and...